EDITORIAL
Why proper characterization of breast cancer subtypes makes a difference in patient care
Shahla Masood MD,
Corresponding Author
Shahla Masood MD
Department of Pathology and Laboratory Medicine, University of Florida College of Medicine – Jax, Jacksonville, FL, USA
Correspondence
Shahla Masood, Department of Pathology and Laboratory Medicine, University of Florida College of Medicine – Jax, Jacksonville, FL, USA.
Email: [email protected]
Search for more papers by this authorShahla Masood MD,
Corresponding Author
Shahla Masood MD
Department of Pathology and Laboratory Medicine, University of Florida College of Medicine – Jax, Jacksonville, FL, USA
Correspondence
Shahla Masood, Department of Pathology and Laboratory Medicine, University of Florida College of Medicine – Jax, Jacksonville, FL, USA.
Email: [email protected]
Search for more papers by this authorFirst published: 24 August 2021
No abstract is available for this article.
REFERENCES
- 1Siegel RI, Miller KD, Jemal A. Cancer statistics, 2020. CA: A Cancer J Clin. 2020; 70(1): 7-30.
- 2Woolston C. Breast cancer. Nature. 2015; 527: S101.
- 3 Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490: 61-70.
- 4Banerji S, Cibulskis K, Rangel-Escareno C, et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012; 486: 405-409.
- 5Colleoni M, Rotmensz N, Maisonneuve P, et al. Outcome of special types of luminal breast cancer. Ann Oncol. 2012; 23(6): 1428-1436.
- 6Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005; 93(9): 1046-1052.
- 7Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003; 289(11): 1421-1424.
- 8Zhao S, Ma D, Xiao Y, et al. Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: a large population-based analysis. Eur J Surg Oncol. 2018; 44(4): 420-428.
- 9Xiao Y, Ma D, Ruan M, et al. Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status. Sci Rep. 2017; 7: 10380.
- 10Li CI, Moe RE, Daling JR. Risk of Mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med. 2003; 163(18): 2149-2153.
- 11Winchester DJ, Sahin AA, Tucker SL, Singletary SE. Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence. Ann Surg. 1996; 223(3): 342-347.
- 12Lagios MD, Rose MR, Margolin FR. Tubular carcinoma of the breast: Association with multicentricity, bilaterality, and family history of mammary carcinoma. Am J Clin Pathol. 1980; 73(1): 25-30.
- 13Holland DW, Boucher LD, Mortimer JE. Tubular breast cancer experience at Washington University: a review of the literature. Clin Breast Cancer. 2001; 2(3): 210-214.
- 14Liu GR, Yang Q, Haffty BG, Moran MS. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2009; 75(5): 1304-1308.
- 15Poirier E, Poirier B, Jacob S, et al. Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breast. J Surg Oncol. 2018; 117(6): 1137-1143.
- 16Bae SY, Choi MY, Choi DH, et al. Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristcis and prognosis. J Breast Cancer. 2011; 14(4): 308-313. https://doi.org/10.4048/jbc.2011.14.4.308. Epub 2011 Dec 27.
- 17Frank GA, Danilova NV, Andreeva LL, Nefedova NA. WHO Classification of tumors of the breast, 2012. Arkh Patol. 2013; 75(2): 53-63.
- 18Marrazzo E, Frusone F, Milana F, et al. Mucinous breast cancer: a narrative review of the literature and a retrospective tertiary single-centre analysis. Breast. 2020; 49: 87-92.
- 19Magro G, Cavanaugh B, Palazzo J. Clinico-pathological features of breast myxoma: report of a case with histogenetic considerations. Virchows Arch. 2010; 456(5): 581-586.
- 20Huang K, Misra S, Bagaria SP. Outcomes of patients with invasive mucinous and tubular carcinomas of the breast. Breast J. 2021; 27(9). https://doi.org/10.1111/tbj.14268
